Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study (队列简介:中国糖尿病患者肿瘤发生风险的纵向研究(REACTION研究))
暂无分享,去创建一个
Zhen Ye | Zhengnan Gao | Tao Yang | Meng Dai | Qin Wan | Li Yan | Li Chen | Jichao Sun | Xuefeng Yu | Yan Liu | Shenghan Lai | Guang Ning | Jie Zhang | Qiang Li | Feixia Shen | Jieli Lu | Yu Xu | Yufang Bi | Weiqing Wang | S. Lai | Yu Xu | Weiqing Wang | Y. Bi | Donghui Li | Jieli Lu | Yuhong Chen | Min Xu | Gang Chen | Qiang Li | Q. Su | G. Qin | Q. Wan | M. Dai | Zhengnan Gao | Guixia Wang | F. Shen | Zuojie Luo | Li Chen | Y. Huo | Z. Ye | Xulei Tang | Chao Liu | Youmin Wang | Shengli Wu | H. Deng | Z. Bloomgarden | Jiajun Zhao | Y. Mu | Donghui Li | Qing Su | Yiming Mu | Zachary T Bloomgarden | Min Xu | Lixin Shi | Jie Zhang | Jichao Sun | Zuojie Luo | Liebin Zhao | Jiajun Zhao | Yuhong Chen | Yanan Huo | Guijun Qin | Lulu Chen | Chao Liu | Shengli Wu | Guixia Wang | Xulei Tang | Gang Chen | Youming Wang | Huacong Deng | Lulu Chen | Li Yan | Lie-bin Zhao | Xu Yu | Tao Yang | G. Ning | Yan Liu | Li-xin Shi | Z. Gao | Z. Luo | Zhengnan Gao
[1] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[2] H. Grosse. [Diabetes and cancer]. , 1956, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten.
[3] P. Puska,et al. Cindi health monitor : Proposal for practical guidelines , 2001 .
[4] Edward Giovannucci,et al. Diabetes and Cancer , 2010, Diabetes Care.
[5] Huanzhong Shi,et al. Major causes of death during the past 25 years in China. , 2007, Chinese medical journal.
[6] J. Lewis,et al. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. , 2004, Gastroenterology.
[7] Yan Liu,et al. Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study , 2009, International journal of cancer.
[8] D. Balzi,et al. Sulphonylureas and cancer: a case–control study , 2008, Acta Diabetologica.
[9] S. Majumdar,et al. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin , 2006, Diabetes Care.
[10] R. Elashoff,et al. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. , 2011, Gastroenterology.
[11] S. Krähenbühl,et al. Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer , 2010, Diabetes Care.
[12] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[13] B. Ainsworth,et al. Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ) - Short and long forms , 2005 .
[14] Bei-fan Zhou. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. , 2002, Biomedical and environmental sciences : BES.
[15] M. Woodward,et al. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] M. Woodward,et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. , 2010, The Lancet. Oncology.
[17] P. Donnan,et al. New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.
[18] F. Ovalle. Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16 , 2010 .
[19] K. Dou,et al. Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.
[20] D. Whiting,et al. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. , 2010, Diabetes research and clinical practice.
[21] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[22] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[23] E. Gale,et al. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes , 2009, Diabetologia.
[24] M. Lahti-Koski. Publications of the National Public Health Institute , 2001 .
[25] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[26] G. Ning. Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study , 2012, Journal of diabetes.
[27] Benjamin J. Epstein,et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .